HP (HPQ) Declines More Than Market: Some Information for Investors

HP (HPQ) recently closed down 2.54% at $25.34, underperforming the S&P 500's 0.79% daily loss. The company faces projected year-over-year declines in both quarterly (10.84%) and full-year (8.58%) EPS, despite modest revenue growth forecasts. While HPQ's Forward P/E of 8.43 suggests a discount to its industry average of 11.83, its PEG ratio of 2.11 exceeds the industry's 1.58, and analyst EPS estimates have remained unchanged, contributing to its current Zacks #3 (Hold) rank.

Analysis

HP (HPQ) is exhibiting clear signs of fundamental pressure and market underperformance. The stock's recent 2.54% decline significantly outpaced the losses of major indices, extending a period of relative weakness where its 3.26% monthly gain lagged both the S&P 500's 5.22% rise and its sector's 7.88% gain. The primary concern stems from forward-looking estimates for its upcoming earnings release; while revenues are projected to grow modestly by 1.26%, earnings per share (EPS) are expected to contract sharply by 10.84% year-over-year. This trend of margin compression is forecasted to persist for the full fiscal year, with revenue growth of 1.75% accompanied by an 8.58% decline in EPS. While the stock trades at a discounted Forward P/E of 8.43 versus its industry's 11.83, this is tempered by a less attractive PEG ratio of 2.11, above the industry average of 1.58, suggesting the market is pricing in this weak growth. The lack of upward revisions to analyst estimates over the past 30 days and the resulting Zacks Rank of #3 (Hold) indicate a neutral stance from analysts, awaiting further catalysts.

Key Decisions for Investors

• Investors should weigh the stock's discounted forward P/E ratio against its significant projected earnings decline and a high PEG ratio, which suggest the valuation may be a value trap rather than an opportunity.
• Given that analyst EPS estimates have been static and the stock is rated a 'Hold', it is prudent to monitor for any positive estimate revisions, as these would be a primary catalyst for a change in the stock's trajectory.
• The upcoming earnings report is a critical inflection point; focus should be on whether the company can meet or exceed the low EPS forecast of $0.74 and provide guidance that addresses the apparent margin deterioration.
• Considering the conflicting signals—a strong industry rank versus weak company-specific forecasts—current holders might consider maintaining their position while awaiting earnings, whereas prospective buyers should exercise caution until there is clarity on the profitability outlook.